SEC Form 4 · accession 0001209191-18-046828
Verrica Pharmaceuticals Inc. · VRCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ted White
Officer — President and CEO · Director
Period of report
Jun 19, 2018
Accepted (ET)
Aug 15, 2018 · 4:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001660334
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 19, 2018 | P | 4,500 | $15.00 | A | 4,500 | D |
Table II — derivative securities
No Table II lines on this filing.